Human Papillomavirus Vaccination in Low- and Middle-Income Countries: Progression, Barriers, and Future Prospective

Human Papillomavirus Vaccination in Low- and Middle-Income Countries: Progression, Barriers, and Future Prospective Publisher Pubmed

Ebrahimi N¹ ; Yousefi Z² ; Khosravi G¹ ; Malayeri FE¹ ; Golabi M¹ ; Askarzadeh M¹ ; Shams MH³ ; Ghezelbash B¹ ; Eskandari N¹

Show Affiliations

1. Immunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2. School of Allied Medical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran
3. Department of Medical Immunology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran

Source: Frontiers in Immunology Published:2023

Abstract

Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health problems like genital warts and cancer. The national immunization schedules for individuals before sexual debut, significantly decreased HPV-associated mortality and it will be affordable. However, immunization programs remain vulnerable to macroeconomic factors such as inflation, fiscal policy, employment levels, and national income. This review aims to investigate the association between national income in lower-middle-income countries to explore recent advances and potential issues, as well as how to deal with challenges. Copyright © 2023 Ebrahimi, Yousefi, Khosravi, Malayeri, Golabi, Askarzadeh, Shams, Ghezelbash and Eskandari.

2. Cost-Effectiveness Analysis of the Introduction of Hpv Vaccination of 9-Year-Old-Girls in Iran, Value in Health Regional Issues (2018)

3. Worldwide Prevalence of Human Papillomavirus Among Pregnant Women: A Systematic Review and Meta-Analysis, Reviews in Medical Virology (2023)

Experts (# of related papers)

Safoura Rouholamin (1)

Atefeh Vaezi (1)

Style	Citing Format
MLA	Ebrahimi N, et al.. "Human Papillomavirus Vaccination in Low- and Middle-Income Countries: Progression, Barriers, and Future Prospective." Frontiers in Immunology, vol. 14, no. , 2023, pp. -.
APA	Ebrahimi N, Yousefi Z, Khosravi G, Malayeri FE, Golabi M, Askarzadeh M, Shams MH, Ghezelbash B, Eskandari N (2023). Human Papillomavirus Vaccination in Low- and Middle-Income Countries: Progression, Barriers, and Future Prospective. Frontiers in Immunology, 14(), -.
Chicago	Ebrahimi N, Yousefi Z, Khosravi G, Malayeri FE, Golabi M, Askarzadeh M, Shams MH, Ghezelbash B, Eskandari N. "Human Papillomavirus Vaccination in Low- and Middle-Income Countries: Progression, Barriers, and Future Prospective." Frontiers in Immunology 14, no. (2023): -.
Harvard	Ebrahimi N et al. (2023) 'Human Papillomavirus Vaccination in Low- and Middle-Income Countries: Progression, Barriers, and Future Prospective', Frontiers in Immunology, 14(), pp. -.
Vancouver	Ebrahimi N, Yousefi Z, Khosravi G, Malayeri FE, Golabi M, Askarzadeh M, et al.. Human Papillomavirus Vaccination in Low- and Middle-Income Countries: Progression, Barriers, and Future Prospective. Frontiers in Immunology. 2023;14():-.
BibTex	@article{ author = {Ebrahimi N and Yousefi Z and Khosravi G and Malayeri FE and Golabi M and Askarzadeh M and Shams MH and Ghezelbash B and Eskandari N}, title = {Human Papillomavirus Vaccination in Low- and Middle-Income Countries: Progression, Barriers, and Future Prospective}, journal = {Frontiers in Immunology}, volume = {14}, number = {}, pages = {-}, year = {2023} }
RIS	TY - JOUR AU - Ebrahimi N AU - Yousefi Z AU - Khosravi G AU - Malayeri FE AU - Golabi M AU - Askarzadeh M AU - Shams MH AU - Ghezelbash B AU - Eskandari N TI - Human Papillomavirus Vaccination in Low- and Middle-Income Countries: Progression, Barriers, and Future Prospective JO - Frontiers in Immunology VL - 14 IS - SP - EP - PY - 2023 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract